Plasma exosomal microRNA profiling in diabetic foot ulcers: inflammatory and proliferative stages—an observational study

BACKGROUND: Diabetic foot ulcers (DFU) are chronic, hard-to-heal wounds that drive diabetic lower-limb complications and can ultimately lead to amputation. Exosomal microRNAs (miRNAs) are promising regulators of ulcer repair by modulating inflammation, promoting angiogenesis, enhancing collagen deposition, and facilitating epithelial regeneration. This study profiled plasma exosomal miRNAs across DFU stages to clarify healing mechanisms and identify potential therapeutic targets. METHODS: Whole-blood samples were collected from patients with uncomplicated type 2 diabetes (DM, n = 6) and patients with DFU (n = 13), including an inflammatory-stage group (DFI, n = 7) and a proliferative-stage group (DFP, n = 6).Plasma exosomes were isolated and characterized by transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. Next-generation sequencing was used to compare exosomal miRNA expression between DFU stages and DM, followed by RT-qPCR validation of differentially expressed miRNAs. Bioinformatics analyses were performed to assess involved pathways. RESULTS: By comparing the plasma exosomal miRNA profiles of patients with DM and DFU, we found that hsa-miR-744-5p, hsa-miR-432-5p, and hsa-miR-1307-3p were upregulated, whereas hsa-miR-15b -5p, hsa-miR-15a-5p and hsa-miR-144-3p were downregulated in DFU versus DM. RT-qPCR validation confirmed the consistent upregulation of only hsa-miR-744-5p and hsa-miR-1307-3p. KEGG enrichment analysis revealed that the dysregulated miRNAs were primarily associated with inflammation- and angiogenesis-related pathways. CONCLUSIONS: The microRNA profiles of plasma exosomes are associated with healing failure in diabetic foot ulcers, with hsa-miR-744-5p and hsa-miR-1307-3p showing sustained upregulation. This suggests that the inflammation-angiogenesis pathway may be involved, indicating that these plasma exosome miRNAs could serve as potential therapeutic targets for DFU. TRIAL REGISTRATION: Registration number ChiCTR2500104621; registration date 19 June 2025.

Authors

Institutions

Publication Details

Journal
Molecular Biology Reports
Published
2026-11-12
DOI
https://doi.org/10.1007/s11033-026-13073-2
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Plasma exosomal microRNA profiling in diabetic foot ulcers: inflammatory and proliferative stages—an observational study

Yuebin Zhao, Hong Su, Yajing Shi, Lixia Liu et al.
Molecular Biology Reports
Extracellular vesicles in disease
article

Plasma exosomal microRNA profiling in diabetic foot ulcers: inflammatory and proliferative stages—an observational study

Yuebin Zhao, Hong Su, Yajing Shi, Lixia Liu, Wenyan Wang, Jingjing Zhang, Meifang He, Xiaoxiao Xin, Li Zhang
article en

Abstract

BACKGROUND: Diabetic foot ulcers (DFU) are chronic, hard-to-heal wounds that drive diabetic lower-limb complications and can ultimately lead to amputation. Exosomal microRNAs (miRNAs) are promising regulators of ulcer repair by modulating inflammation, promoting angiogenesis, enhancing collagen deposition, and facilitating epithelial regeneration. This study profiled plasma exosomal miRNAs across DFU stages to clarify healing mechanisms and identify potential therapeutic targets. METHODS: Whole-blood samples were collected from patients with uncomplicated type 2 diabetes (DM, n = 6) and patients with DFU (n = 13), including an inflammatory-stage group (DFI, n = 7) and a proliferative-stage group (DFP, n = 6).Plasma exosomes were isolated and characterized by transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. Next-generation sequencing was used to compare exosomal miRNA expression between DFU stages and DM, followed by RT-qPCR validation of differentially expressed miRNAs. Bioinformatics analyses were performed to assess involved pathways. RESULTS: By comparing the plasma exosomal miRNA profiles of patients with DM and DFU, we found that hsa-miR-744-5p, hsa-miR-432-5p, and hsa-miR-1307-3p were upregulated, whereas hsa-miR-15b -5p, hsa-miR-15a-5p and hsa-miR-144-3p were downregulated in DFU versus DM. RT-qPCR validation confirmed the consistent upregulation of only hsa-miR-744-5p and hsa-miR-1307-3p. KEGG enrichment analysis revealed that the dysregulated miRNAs were primarily associated with inflammation- and angiogenesis-related pathways. CONCLUSIONS: The microRNA profiles of plasma exosomes are associated with healing failure in diabetic foot ulcers, with hsa-miR-744-5p and hsa-miR-1307-3p showing sustained upregulation. This suggests that the inflammation-angiogenesis pathway may be involved, indicating that these plasma exosome miRNAs could serve as potential therapeutic targets for DFU. TRIAL REGISTRATION: Registration number ChiCTR2500104621; registration date 19 June 2025.

Molecular Biology ReportsVol. 53(1)
Shanxi Medical University (CN), Taiyuan Central Hospital (CN)
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon